Cero Therapeutics Holdings CERO
OTC CERO
$0.00 +0.00 (+0.00%)
At close: Oct 21, 2026 · 4:00 PM EDT

Cero Therapeutics Holdings, Inc. (CERO) Preferred Stock Liabilities (2021 - 2026)

Updated

Cero Therapeutics Holdings' Preferred Stock Liabilities came in at $14.97 million for Q2 2026.

Analysis

Cero Therapeutics Holdings, Inc. (CERO) Preferred Stock Liabilities (2021 - 2026) Analysis & Trends

At the end of FY2023, Cero Therapeutics Holdings' Preferred Stock Liabilities was $8.44 million, down 37.4% from FY2022.

  • Going back by year, Preferred Stock Liabilities was $13.47 million in FY2022 (-92.5%) and $178.5 million in FY2021.
  • The Q2 2026 figure represents the highest quarterly Preferred Stock Liabilities since Q3 2022.
Peer Set

Peer Comparison

Historic Data

Historic Data

Download Data
DateValue
Jun 30, 2026 14.97 Mn
Dec 31, 2023 8.44 Mn
Sep 30, 2023 8.29 Mn
Jun 30, 2023 13.84 Mn
Mar 31, 2023 13.57 Mn
Dec 31, 2022 13.47 Mn
Sep 30, 2022 179.48 Mn
Jun 30, 2022 178.50 Mn
Mar 31, 2022 178.50 Mn
Dec 31, 2021 178.50 Mn
API Access

Cero Therapeutics Holdings, Inc. Preferred Stock Liabilities API

Pull this series into your own models, spreadsheets and apps with the Business Quant Historical Metrics API. The request below matches the chart above — change the frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.

https://data.businessquant.com/historic?slug=preferred-stock-liabilities&ticker=CERO&period=max&api_key=YOUR_API_KEY